News Detail
New Delhi, 20 Jan 2025: Immuneel Therapeutics, the Bengaluru-based cell and gene therapy company, has launched India's second CAR-T cell therapy Qartemi to treat patients with B-cell Non-Hodgkin Lymphoma (B-NHL) - an aggressive form of blood cancer - at less than one-tenth of the......
View Details
Source : Economic Times
CAR-T cell therapy
blood cancer treatment
Immuneel Therapeutics
B-cell Non-Hodgkin Lymphoma
low-cost cancer therapy
Kiran Mazumdar-Shaw
Chimeric antigen receptor therapy
clinical trial results
oncology
India cancer treatment
Related News
- NPPA fixes retail price of 42 formulations, revise prices based on review orders (11-02-2025)
- DCGI calls for focused interventions to enhance drug quality (11-02-2025)
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)